The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with ...

A study has found that Ozempic may reverse signs of a disease that contributes to 2,000,000 deaths per year. New research has ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement ...